Scarica l'app Stockscreener
15.88
7.08%
-1.21
Pre-mercato:
15.88
Precedente Chiudi:
$17.09
Aprire:
$17.14
Volume 24 ore:
724.65K
Relative Volume:
1.42
Capitalizzazione di mercato:
$866.46M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-3.47%
1M Prestazione:
+14.49%
6M Prestazione:
+6.72%
1 anno Prestazione:
-32.83%
Intervallo 1D:
$15.79
$17.25
Intervallo di 1 settimana:
$15.79
$17.71
Portata 52W:
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
Nome
Bicara Therapeutics Inc
Settore
Industria
Telefono
617-468-4219
Indirizzo
116 HUNTINGTON AVENUE SUITE 703, BOSTON
Confronta BCAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
15.88 | 933.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.25B | 4.58B | 3.56B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-05-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | Iniziato | Wells Fargo | Underweight |
| 2025-02-06 | Iniziato | Wedbush | Outperform |
| 2024-12-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-05 | Iniziato | Rodman & Renshaw | Buy |
| 2024-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-08 | Iniziato | Morgan Stanley | Overweight |
| 2024-10-08 | Iniziato | Stifel | Buy |
| 2024-10-08 | Iniziato | TD Cowen | Buy |
Mostra tutto
Bicara Therapeutics Inc Borsa (BCAX) Ultime notizie
Why Bicara Therapeutics Inc. stock is considered a top pickWeekly Trend Recap & Real-Time Buy Signal Alerts - newser.com
Will Bicara Therapeutics Inc. stock benefit from automationGlobal Markets & Consistent Profit Trading Strategies - newser.com
How Bicara Therapeutics Inc. stock benefits from global expansionQuarterly Profit Report & Fast Gain Swing Trade Alerts - newser.com
How Bicara Therapeutics Inc. stock compares to market leadersEarnings Summary Report & Breakout Confirmation Trade Signals - newser.com
Real time alert setup for Bicara Therapeutics Inc. performance2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com
How institutional buying supports Bicara Therapeutics Inc. stockPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
What risks investors should watch in Bicara Therapeutics Inc. stockJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
Is Bicara Therapeutics Inc. stock resilient to inflationGap Up & Breakout Confirmation Trade Signals - newser.com
Is Bicara Therapeutics Inc. stock safe for conservative investors2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
Is Bicara Therapeutics Inc. stock a contrarian buyWeekly Trade Review & Detailed Earnings Play Strategies - Fundação Cultural do Pará
What institutional flow reveals about Bicara Therapeutics Inc.Earnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Will Bicara Therapeutics Inc. stock see insider buyingEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Is Bicara Therapeutics Inc. stock a buy before product launches2025 Technical Overview & Growth Focused Stock Reports - newser.com
Bicara Therapeutics’ FORTIFI-HN01 Study: A Promising Step in Cancer Treatment - TipRanks
Bicara Therapeutics’ Innovative Approach to EGFR-Driven Tumors: A Clinical Study Update - TipRanks
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology - Benzinga
Bicara Therapeutics Inc Azioni (BCAX) Dati Finanziari
Non sono disponibili dati finanziari per Bicara Therapeutics Inc (BCAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.71%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):